公司资料
Alcon Inc. 股价、新闻与催化剂
- 股票代码:
- ALC
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- Switzerland and listed in the U
股票表现
63.76 USD (-0.28%)
收盘价
最后更新: 2026年10月2日
31.3B USD
市值
股价为何变动
截至 2026年10月2日，ALC 下跌 0.28%，收于 $63.76。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Global Eye Care Company
Alcon is a global eye care company with surgical and vision-care products used in more than 140 countries and territories. Its portfolio addresses cataracts, refractive errors, glaucoma, retinal disease, contact-lens needs, and ocular surface conditions.
Surgical Equipment and Consumables
The Surgical segment provides cataract and vitreoretinal systems, intraocular lenses, visualization technologies, surgical packs, and related consumables. Installed equipment supports recurring demand for procedure-specific products and service.
Intraocular Lens Portfolio
Alcon offers monofocal, toric, and presbyopia-correcting intraocular lenses for cataract surgery. Premium lenses and delivery systems are designed to improve visual outcomes while expanding the range of vision correction available to surgeons and patients.
Vision Care Franchise
Vision Care includes daily and reusable contact lenses, lens-care solutions, and ocular health products. Brands and product platforms span silicone hydrogel lenses, multifocal and toric designs, dry-eye care, and consumer lens maintenance.
Digital and Refractive Technologies
Alcon is building connected cataract workflows through its Adi digital ecosystem and maintains a large refractive-surgery portfolio through WaveLight. Partnerships in adjustable lenses and other optical technologies extend the company's innovation beyond its current product base.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。